Expert Analysis: Direct U.S. Filing vs. PCT National Stage Entry
For a founder based outside the United States, the choice between a direct §111(a) filing and a §371 national stage entry gets framed as a deadline question. It is really a fee-architecture question. The two routes are priced from different sections of the fee schedule — §1.16 for direct filings, §1.492 for national stage entry — and the two schedules do not mirror each other. The gap runs into four figures before a single professional hour is billed.
1. The search report discount is the largest single lever
At the national stage, the search fee is tiered by how much searching has already been done. If the USPTO itself acted as the International Searching Authority, the search fee falls to $150 for a large entity. If a different ISA prepared an international search report and that report was provided to the Office, the fee is $580. With no usable report on file, you pay the full $770. That is a $620 spread on one line item, claimed by identifying the correct tier when you pay — not by argument. A direct non-PCT filing has no equivalent: the search fee is charged in full regardless of what any foreign office already found.
2. Your ISA election is a downstream cost decision
Applicants filing through a receiving office such as the KIPO can usually elect among several competent authorities. Electing the USPTO produces the deepest national stage discount and, where the U.S. also served as IPEA and every claim satisfies PCT Article 33(1)–(4), can zero out the examination fee entirely. Electing the EPO typically costs more upfront but can spare a supplementary European search later. The right answer depends on where the family actually lands: if the U.S. is the primary market, choosing the U.S. as ISA converts an international fee into a domestic discount. Deciding after the search report issues is deciding too late.
3. The discount structures are not symmetrical
The 60% small entity and 80% micro entity reductions apply on both routes, but the underlying line items differ in ways most estimates miss. The clearest example sits in the basic filing fee: §1.16(a) grants a small entity an additional reduction when the application is filed through the electronic filing system, taking the basic fee to $70. The basic national fee under §1.492(a) has no such provision — a small entity pays $140 whichever way the papers arrive. The direct route, in exchange, carries surcharge exposure the national stage does not. Read the two schedules side by side rather than assuming one discount logic governs both.
How I actually decide
Excess claim fees are identical on both routes — $600 per independent claim over three, $200 per claim over twenty, $925 where a multiple dependent claim appears — so trim the claim set before comparing anything else. Then model two scenarios: a §371 entry with a favourable search report, against a bypass continuation under §111(a) that forfeits the search fee tier but restores direct-route flexibility and amendment practice. The cheaper route is rarely the one intuition picks.
| Cost element | Direct filing (§111(a) / §1.16) | National stage (§371 / §1.492) |
|---|---|---|
| Basic fee (large) | $350 | $350 |
| Small entity basic fee | $140, or $70 filed electronically | $140 — no electronic reduction |
| Search fee (large) | $770 flat | $150 / $580 / $770 by tier |
| Examination fee (large) | $880 | $880, or $0 where §1.492(c)(1) applies |
| Excess claim fees | Identical | Identical |
| Practical deadline | Priority year (12 months) | 30 months from priority |
The one number worth re-checking
Before you wire funds, confirm the international search report is of record at the USPTO. The middle search fee tier depends on it, and an ISR that has not reached the Office turns a $580 line item into $770 plus a response deadline you did not budget for.